S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Is Gold Really Boring? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Stocks That Really, Really Need the Defense Bill to Pass
Is Gold Really Boring? (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Stock market today: World shares mixed after Wall Street retreat deepens
Is Gold Really Boring? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
US consumer confidence tumbles in September as American anxiety about the future grows
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Is Gold Really Boring? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Stocks That Really, Really Need the Defense Bill to Pass
Is Gold Really Boring? (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Stock market today: World shares mixed after Wall Street retreat deepens
Is Gold Really Boring? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
US consumer confidence tumbles in September as American anxiety about the future grows
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Is Gold Really Boring? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Stocks That Really, Really Need the Defense Bill to Pass
Is Gold Really Boring? (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Stock market today: World shares mixed after Wall Street retreat deepens
Is Gold Really Boring? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
US consumer confidence tumbles in September as American anxiety about the future grows
S&P 500   4,273.53
DOW   33,618.88
QQQ   354.21
5 Oversold Semiconductor Stocks to Nibble On Ahead of Q3 Earnings
Is Gold Really Boring? (Ad)
3 Warren Buffett Stocks that are Moving into the Buy Zone
3 Stocks That Really, Really Need the Defense Bill to Pass
Is Gold Really Boring? (Ad)
JPMorgan to pay $75 million on claims that it enabled Jeffrey Epstein's sex trafficking operations
Stock market today: World shares mixed after Wall Street retreat deepens
Is Gold Really Boring? (Ad)
AI Race Accelerates with Amazon's Investment In Anthropic
US consumer confidence tumbles in September as American anxiety about the future grows
NASDAQ:OFIX

Orthofix Medical (OFIX) Stock Forecast, Price & News

$12.40
-0.29 (-2.29%)
(As of 09/26/2023 ET)
Compare
Today's Range
$12.38
$12.78
50-Day Range
$12.40
$21.36
52-Week Range
$12.26
$23.19
Volume
585,511 shs
Average Volume
724,965 shs
Market Capitalization
$455.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
29.0% Upside
$16.00 Price Target
Short Interest
Healthy
1.76% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.41mentions of Orthofix Medical in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$101,025 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.66) to ($0.43) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

289th out of 963 stocks

Surgical & Medical Instruments Industry

35th out of 98 stocks


OFIX stock logo

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates spine and orthopedics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through Global Spine and Global Orthopedics segments. The Global Spine segment comprises the bone growth therapies products, which manufactures and distributes bone growth stimulator devices for enhance of bone fusion including adjunctive and noninvasive treatment of cervical and lumbar spine as well as a therapeutic treatment for non-spine; the spinal implants products designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and the biological products, such as regenerative products and tissue forms which allow physicians to treat a variety of spinal and orthopedic conditions. Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions unrelated to the spine, which design, develop, and market the orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. It sells its products through distributors, sales representatives, hospitals, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.

OFIX Price History

OFIX Stock News Headlines

Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
Orthofix Ongoing Investor Alert
Orthofix Shareholder Action Reminder
Is Gold Really Boring?
Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks.
BTIG Downgrades Orthofix Medical (OFIX)
JMP Securities Sticks to Their Hold Rating for Orthofix (OFIX)
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings
8/08/2023
Today
9/27/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,092
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$16.00
High Stock Price Forecast
$16.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+29.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-19,750,000.00
Pretax Margin
-19.15%

Debt

Sales & Book Value

Annual Sales
$460.71 million
Cash Flow
$1.87 per share
Book Value
$16.71 per share

Miscellaneous

Free Float
35,012,000
Market Cap
$455.58 million
Optionable
Optionable
Beta
0.85

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Ms. Catherine M. Burzik M.A.Ms. Catherine M. Burzik M.A. (Age 73)
    MA, Interim CEO & Chair of the Board
    Comp: $137.5k
  • Ms. Kimberley A. EltingMs. Kimberley A. Elting (Age 58)
    Pres of Global Orthopedics
    Comp: $766.67k
  • Mr. Kevin J. Kenny (Age 58)
    Pres of Global Spine Bus.
    Comp: $607.64k
  • Mr. Geoffrey C. Gillespie
    VP, Corp. Controller & Interim CFO
  • Mr. Roberto Donadello
    Sr. VP of Global Operations
  • Dr. Frank Vizesi Ph.D.
    Chief Scientific Officer
  • Mr. Dan E. Yarbrough
    VP of Investor Relations
  • Ms. Puja Leekha
    Sr. VP, Chief Ethics & Compliance Officer and Interim Chief Legal Officer
  • Ms. Suzanne Armstrong
    Chief HR Officer
  • Mr. Ehab M. Esmail (Age 51)
    Sr. VP of Global Quality, Regulatory & Clinical Affairs













OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price forecast for 2023?

2 brokerages have issued 12 month price targets for Orthofix Medical's shares. Their OFIX share price forecasts range from $16.00 to $16.00. On average, they predict the company's share price to reach $16.00 in the next twelve months. This suggests a possible upside of 29.0% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2023?

Orthofix Medical's stock was trading at $20.53 at the beginning of 2023. Since then, OFIX stock has decreased by 39.6% and is now trading at $12.40.
View the best growth stocks for 2023 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) announced its earnings results on Tuesday, August, 8th. The medical device company reported $0.02 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.67) by $0.69. The medical device company had revenue of $187.02 million for the quarter, compared to the consensus estimate of $183.80 million. Orthofix Medical had a negative net margin of 19.74% and a negative trailing twelve-month return on equity of 1.90%.

What ETF holds Orthofix Medical's stock ?

Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $752.00 million-$758.00 million, compared to the consensus revenue estimate of $750.57 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.30%), Rubric Capital Management LP (6.55%), Segall Bryant & Hamill LLC (5.65%), State Street Corp (4.33%), Dimensional Fund Advisors LP (3.23%) and Paradice Investment Management LLC (2.58%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar.
View institutional ownership trends
.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $12.40.

How much money does Orthofix Medical make?

Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $455.58 million and generates $460.71 million in revenue each year. The medical device company earns $-19,750,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis.

How many employees does Orthofix Medical have?

The company employs 1,092 workers across the globe.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -